Thrombin activates envelope glycoproteins of HIV type 1 and enhances fusion
- 1 April 2004
- journal article
- Published by Elsevier in Microbes and Infection
- Vol. 6 (5) , 414-420
- https://doi.org/10.1016/j.micinf.2004.01.010
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Activation of gp120 of human immunodeficiency virus by their V3 loop-derived peptidesBiochemical and Biophysical Research Communications, 2002
- Thrombin-induced expression of RANTES mRNA through protease activated receptor-1 in human synovial fibroblastsAnnals of the Rheumatic Diseases, 2002
- Inhibiting HIV-1 EntryCell, 1999
- Effect of Changes in the Glycosylation of the Human Immunodeficiency Virus Type 1 Envelope on the Immunoreactivity and Sensitivity to Thrombin of Its Third Variable DomainVirology, 1998
- CD4-Independent Infection by HIV-2 Is Mediated by Fusin/CXCR4Cell, 1996
- T‐cell Membrane‐Associated Serine Protease, Tryptase TL2, Binds Human Immunodeficiency Virus Type 1 gp120 and Cleaves the Third‐Variable‐Domain Loop of gp120European Journal of Biochemistry, 1996
- Inhibition of U‐937 membrane‐associated cathepsin G by GP 120 (IIIB) and V3 loop‐derived peptides from several strains of HIV‐1FEBS Letters, 1995
- Effect of Mutations in the V3 Loop of HIV-1 gp120 on Infectivity and Susceptibility to Proteolytic CleavageAIDS Research and Human Retroviruses, 1993
- A chink in HIV's armour?Nature, 1990
- Generation of human monoclonal antibodies to human immunodeficiency virus.Proceedings of the National Academy of Sciences, 1989